Andrew Witty — Board Member Accountability Profile
Corporate Board Members

Andrew Witty — Board Member Accountability Profile

Skip to main content
Table of Contents
< All Topics
Print

Andrew Witty — Board Member Accountability Profile

This article has been corrected. 1 correction — see Corrections at the end of this article.

Last updated: October 23, 2026

Category: Private Citizen — Corporate Executive Director Role: Former CEO & Director, UnitedHealth Group Inc. (UNH) Board Tenure: 2021 – 2025 (resigned as CEO effective May 12, 2025; not named among the directors in the 2026 proxy statement) Committee Memberships: None (CEO capacity) Profile Type: Board Member Accountability — Anchor B (Documented Organizational Leadership)


Basis for Inclusion: Andrew Witty held documented executive and governance authority as CEO and director of UnitedHealth Group Inc. As operating CEO, Witty bore primary operational responsibility for UnitedHealth’s regulatory engagement, government contract relationships, and political strategy. UnitedHealth’s Optum segment is one of the largest federal government healthcare contractors. The Change Healthcare data breach in 2024 — which disrupted payments across U.S. healthcare — and subsequent litigation occurred under Witty’s tenure. This profile documents the factual governance relationship, not the subject’s personal political views.

Subject Classification: Private Citizen / Corporate Executive Director. Board membership and executive role are matters of public record (SEC filings, proxy statements). This profile documents only the governance role and its connection to documented corporate political activity.


Biographical Overview

Andrew Witty (born March 6, 1964) was CEO of UnitedHealth Group from February 2021 until his resignation effective May 12, 2025, and was previously CEO of Optum, UnitedHealth’s technology and services segment, beginning 2019. Before UnitedHealth, he served as CEO of GlaxoSmithKline (GSK) from 2008 to 2017, where he managed one of the world’s largest pharmaceutical companies through drug pricing controversies, bribery settlements in China, and manufacturing challenges. He was knighted by Queen Elizabeth II in 2012 for services to the pharmaceutical industry.

Witty’s tenure at UnitedHealth has been marked by the 2024 cyberattack on Change Healthcare — a UnitedHealth subsidiary — that was the largest healthcare data breach in U.S. history. The attack disrupted payment processing across tens of thousands of healthcare providers and prompted Congressional hearings. He testified before both the Senate Finance Committee and the Energy & Commerce Committee in May 2024 regarding the breach.

He holds a B.A. in Business Studies from the University of Nottingham.


Board Role and Governance Authority

  • Company: UnitedHealth Group Inc. (NYSE: UNH)
  • Board tenure: 2021 – 2025 (resigned as CEO effective May 12, 2025; not named among the directors in the 2026 proxy statement)
  • Executive role: CEO (February 2021 – May 12, 2025)

SourceUnitedHealth Group Incorporated DEF 14A Proxy Statement, filed April 21, 2026; SEC EDGAR accession 0001104659-26-046125: https://www.sec.gov/Archives/edgar/data/731766/000110465926046125/tm261387-6_def14a.htm


Parent Corporate Donor Profile

This profile is a governance-accountability companion to the UnitedHealth Group corporate donor profile, which documents the corporation’s political spending and regulatory relationships under the Trump administration.



Factual correction requests: If you believe information in this profile is incorrect, please contact factcheck@citizenanalyst.ai with your name (optional), the specific claim, and any supporting documentation. We review all submissions and correct verified errors promptly.


Investigative trail pointers (public records)

Education only — verify independently. Absence of hits is not proof.

Channel Starting points
Federal courts CourtListener / PACER party and attorney searches (spelling variants)
Campaign finance FEC + OpenSecrets for committees and donors tied to documented roles
Corporate / LLC State secretary of state; OpenCorporates for cross-border shells from reporting
Sanctions / PEP OpenSanctions when international business context is already sourced
Contracts / grants USAspending.gov for named entities from investigations

Use public-records-research-specialist, corporate-intelligence-investigator, and public-corruption-ombudsman evidence tiers.

Sources

  • UnitedHealth Group Inc. DEF 14A Proxy Statement, filed April 21, 2025; SEC EDGAR (CIK 731766) (SEC EDGAR filings)
  • UnitedHealth Group Incorporated DEF 14A Proxy Statement, filed April 21, 2026; SEC EDGAR accession 0001104659-26-046125: https://www.sec.gov/Archives/edgar/data/731766/000110465926046125/tm261387-6_def14a.htm

Corrections

Correction [2026-11-01]: An earlier version described Andrew Witty as UnitedHealth’s current CEO and a director. UnitedHealth’s 2026 proxy statement says he resigned as CEO effective May 12, 2025, and does not name him among its directors. Source: https://www.sec.gov/Archives/edgar/data/731766/000110465926046125/tm261387-6_def14a.htm.

Was this article helpful?
0 out of 5 stars
5 Stars 0%
4 Stars 0%
3 Stars 0%
2 Stars 0%
1 Stars 0%
5
Please Share Your Feedback
How Can We Improve This Article?